Jinxin Fertility FY26 H1 swings to profit of RMB 110.3 million; revenue rises 6.6% to RMB 1.37 billion
The Hong Kong Market's "Leftover" Bin: Who's Faking It and Who's Real?
Hong Kong Niche Plays: Tech Upgrades and Fertility Turnarounds to Watch
The Capital Allocation Shift: Micro-Narratives Across Hong Kong's Fragmented Market
Jinxin Fertility schedules board meeting to review interim results
The Folded Corners of Hong Kong's Market: From Fertility Clinics to Leveraged ETFs